CN103550643A - Traditional Chinese medicine for treating tuberculosis - Google Patents
Traditional Chinese medicine for treating tuberculosis Download PDFInfo
- Publication number
- CN103550643A CN103550643A CN201310532331.5A CN201310532331A CN103550643A CN 103550643 A CN103550643 A CN 103550643A CN 201310532331 A CN201310532331 A CN 201310532331A CN 103550643 A CN103550643 A CN 103550643A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- traditional chinese
- take
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating tuberculosis. The traditional Chinese medicine is prepared from the following raw materials in percentage by weight: 10-20 parts of root of straight ladybell, 5-12 parts of pericarpium citri reticulatae, 20-30 parts of radix stemonae, 10-20 parts of almond, 15-25 parts of root of rehmannia, 4-10 parts of radix ophiopogonis, 20-30 parts of mulberry bark, 8-15 parts of pinellia ternate, 6-14 parts of rhizoma anemarrhenae, 10-20 parts of radix asteris and 3-8 parts of radix platycodi. The traditional Chinese medicine for treating tuberculosis takes the radix stemonae and the mulberry bark as main medicines and is combined with other adjuvants, and the main medicines and the adjuvants act with each other to take a synergistic effect, so as to take excellent effects of strengthening spleen and tonifying lung, nourishing yin and clearing internal heat, tranquilizing yang and protecting lung, supplementing qi and promoting production of body fluid; the traditional Chinese medicine has good treating effect on patients of tuberculosis, and is durable in action, safe and free from side effect, simple in preparation method and convenient to take.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of phthisical Chinese medicine for the treatment of.
Background technology
Tuberculosis is the chronic infectious disease being caused by mycobacterium tuberculosis, can invade and many internal organs ,Yi pulmonary tuberculosis infection the most common.Excreter is its important source of infection.Not necessarily morbidity after human infection tulase, when resistance reduces or when cell-mediated allergy increases, just may cause clinical onset.The onset of tuberculosis patient can suddenly can be delayed, and mostly is low grade fever (afternoon for work), night sweat, weak, poor appetite, becomes thin, female menstrual disorder etc.; Respiratory symptom has cough, expectoration, spitting of blood, chest pain, uncomfortable in chest or dyspnea in various degree.If can diagnose in time, and give rational therapy, mostly can obtain clinical recovery.The phthisical medicine for the treatment of is a lot of at present, for example publication number is: CN101954027A, name are called the Chinese invention patent application that < < treats phthisical Chinese medicine > >, disclose especially a kind of phthisical Chinese medicine for the treatment of.This Chinese medicine be take Herba Houttuyniae, Pseudobulbus Bletillae (Rhizoma Bletillae), Semen Ginkgo, the Radix Stemonae, Bulbus Fritillariae Thunbergii, the Rhizoma Anemarrhenae, Herba Portulacae, Cortex Lycii, the Radix Astragali, Radix Glycyrrhizae, Herba Cirsii, Cacumen Platycladi, Radix Platycodonis, Caulis Cucurbitae, Herba Potentillae Discoloris, Umbillcaria esculenta and Flos Farfarae as raw material, composes according to a certain number of weight copies.The present invention prepares simply, and good absorbing effect is evident in efficacy, has no side effect, safe, is conducive to sufferer and alleviates in time condition of illness.But the compatibility of medicine is comparatively complicated.
Summary of the invention
The technical problem to be solved in the present invention is to provide the phthisical Chinese medicine for the treatment of that a kind of compatibility is comparatively simple, safe and reliable, therapeutic effect is good.
For solving the problems of the technologies described above, the present invention by the following technical solutions:
The present invention treats phthisical Chinese medicine, is to be made by the raw material of following weight proportioning:
Radix Adenophorae (Radix Glehniae) 10~20, Pericarpium Citri Reticulatae 5~12, the Radix Stemonae 20~30, Semen Armeniacae Amarum 10~20, the Radix Rehmanniae 15~25, Radix Ophiopogonis 4~10, Cortex Mori 20~30, the Rhizoma Pinelliae 8~15, the Rhizoma Anemarrhenae 6~14, Radix Asteris 10~20, Radix Platycodi (Radix Platycodonis) 3~8.
The preferred weight proportioning of each raw material is:
Radix Adenophorae (Radix Glehniae) 12~18, Pericarpium Citri Reticulatae 6~10, the Radix Stemonae 22~28, Semen Armeniacae Amarum 12~18, the Radix Rehmanniae 18~22, Radix Ophiopogonis 5~9, Cortex Mori 22~28, the Rhizoma Pinelliae 10~13, the Rhizoma Anemarrhenae 7~12, Radix Asteris 12~18, Radix Platycodi (Radix Platycodonis) 4~7.
The optimum weight proportioning of each raw material is:
Radix Adenophorae (Radix Glehniae) 16, Pericarpium Citri Reticulatae 8, the Radix Stemonae 25, Semen Armeniacae Amarum 15, the Radix Rehmanniae 20, Radix Ophiopogonis 6, Cortex Mori 25, the Rhizoma Pinelliae 12, the Rhizoma Anemarrhenae 9, Radix Asteris 15, Radix Platycodi (Radix Platycodonis) 5.
The preparation method that the present invention treats phthisical Chinese medicine is: take by weight ratio raw material Radix Adenophorae (Radix Glehniae), Pericarpium Citri Reticulatae, the Radix Stemonae, Semen Armeniacae Amarum, the Radix Rehmanniae, Radix Ophiopogonis, Cortex Mori, the Rhizoma Pinelliae, the Rhizoma Anemarrhenae, Radix Asteris, Radix Platycodi (Radix Platycodonis), add the decocting of 8~12 times of raw material weights to boil, after water boils, slow fire boils 50~80 minutes, leach medicinal liquid, obtain.
The instructions of taking that the present invention treats phthisical Chinese medicine is: oral, every day 2 times, each serving 300~400 grams.
The present invention treats phthisical Chinese medicine, and to take the Radix Stemonae and Cortex Mori be principal agent, other accessory drugs of arranging in pairs or groups, they influence each other, synergism, thereby play the fine effect that has spleen invigorating lung benefiting, nourishing YIN and clearing away fire, YANG hyperactivity suppressing to protect lung, supplementing QI for promoting the production of body fluid, lunger is had to good therapeutic effect, and its effect is lasting, safety has no side effect, preparation method is simple, and it is also convenient to take.
The specific embodiment
With embodiment, the invention will be further described below, but the present invention is not limited to these embodiment.
Umber described in following embodiment is weight portion.
Embodiment 1
Drug weight proportioning:
10 parts of Radix Adenophorae (Radix Glehniae), 5 parts of Pericarpium Citri Reticulataes, 20 parts of the Radixs Stemonae, 10 parts, Semen Armeniacae Amarum, 15 parts, the Radix Rehmanniae, 4 parts of Radix Ophiopogonis, 20 parts of Cortex Mori, 8 parts of the Rhizoma Pinelliaes, 6 parts of the Rhizoma Anemarrhenaes, 10 parts of Radix Asteriss, 3 parts of Radix Platycodi (Radix Platycodonis).
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 8 times of raw material weights to boil, after water boils, slow fire boils 50 minutes, leaches medicinal liquid, obtains.
Embodiment 2
Drug weight proportioning:
20 parts of Radix Adenophorae (Radix Glehniae), 12 parts of Pericarpium Citri Reticulataes, 30 parts of the Radixs Stemonae, 20 parts, Semen Armeniacae Amarum, 25 parts, the Radix Rehmanniae, 10 parts of Radix Ophiopogonis, 30 parts of Cortex Mori, 15 parts of the Rhizoma Pinelliaes, 14 parts of the Rhizoma Anemarrhenaes, 20 parts of Radix Asteriss, 8 parts of Radix Platycodi (Radix Platycodonis).
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 10 times of raw material weights to boil, after water boils, slow fire boils 65 minutes, leaches medicinal liquid, obtains.
Embodiment 3
Drug weight proportioning:
16 parts of Radix Adenophorae (Radix Glehniae), 8 parts of Pericarpium Citri Reticulataes, 25 parts of the Radixs Stemonae, 15 parts, Semen Armeniacae Amarum, 20 parts, the Radix Rehmanniae, 6 parts of Radix Ophiopogonis, 25 parts of Cortex Mori, 12 parts of the Rhizoma Pinelliaes, 9 parts of the Rhizoma Anemarrhenaes, 15 parts of Radix Asteriss, 5 parts of Radix Platycodi (Radix Platycodonis).
Preparation method:
By above-mentioned weight proportion, take raw material, add the decocting of 12 times of raw material weights to boil, after water boils, slow fire boils 80 minutes, leaches medicinal liquid, obtains.
Experimental example:
Below example is further set forth the beneficial effect that the present invention treats phthisical Chinese medicine by experiment.
1, experiment crowd:
Be divided into A, two experimental grouies of B:
A group: pulmonary tuberculosis female patient 90 examples; 25~35 years old age.
B group: pulmonary tuberculosis male patient's 86 examples; 35~45 years old age.
2, drug administration method:
The oral embodiment of the present invention 3 makes the phthisical Chinese medicine for the treatment of every day 2 times, each serving 400 grams, serve on 60 days.
3, efficacy evaluation:
(1) invalid: with take medicine before compare, without significant change.
(2) effective: effect is remarkable.
4, therapeutic effect:
Claims (3)
1. treat a phthisical Chinese medicine, it is characterized in that being made by the raw material of following weight proportioning:
Radix Adenophorae (Radix Glehniae) 10~20, Pericarpium Citri Reticulatae 5~12, the Radix Stemonae 20~30, Semen Armeniacae Amarum 10~20, the Radix Rehmanniae 15~25, Radix Ophiopogonis 4~10, Cortex Mori 20~30, the Rhizoma Pinelliae 8~15, the Rhizoma Anemarrhenae 6~14, Radix Asteris 10~20, Radix Platycodi (Radix Platycodonis) 3~8.
2. the phthisical Chinese medicine for the treatment of according to claim 1, is characterized in that the weight proportion of each raw material is:
Radix Adenophorae (Radix Glehniae) 12~18, Pericarpium Citri Reticulatae 6~10, the Radix Stemonae 22~28, Semen Armeniacae Amarum 12~18, the Radix Rehmanniae 18~22, Radix Ophiopogonis 5~9, Cortex Mori 22~28, the Rhizoma Pinelliae 10~13, the Rhizoma Anemarrhenae 7~12, Radix Asteris 12~18, Radix Platycodi (Radix Platycodonis) 4~7.
3. the phthisical Chinese medicine for the treatment of according to claim 2, is characterized in that the weight proportion of each raw material is:
Radix Adenophorae (Radix Glehniae) 16, Pericarpium Citri Reticulatae 8, the Radix Stemonae 25, Semen Armeniacae Amarum 15, the Radix Rehmanniae 20, Radix Ophiopogonis 6, Cortex Mori 25, the Rhizoma Pinelliae 12, the Rhizoma Anemarrhenae 9, Radix Asteris 15, Radix Platycodi (Radix Platycodonis) 5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310532331.5A CN103550643A (en) | 2013-10-31 | 2013-10-31 | Traditional Chinese medicine for treating tuberculosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310532331.5A CN103550643A (en) | 2013-10-31 | 2013-10-31 | Traditional Chinese medicine for treating tuberculosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103550643A true CN103550643A (en) | 2014-02-05 |
Family
ID=50005116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310532331.5A Pending CN103550643A (en) | 2013-10-31 | 2013-10-31 | Traditional Chinese medicine for treating tuberculosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103550643A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104815259A (en) * | 2015-05-23 | 2015-08-05 | 青岛辰达生物科技有限公司 | Traditional Chinese medicine composition for treating phthisis |
CN105031445A (en) * | 2015-06-29 | 2015-11-11 | 梁忠顺 | Chinese medicinal composition for treating pulmonary tuberculosis |
CN105726906A (en) * | 2016-05-11 | 2016-07-06 | 刘晓 | Traditional Chinese medicine for treating pulmonary tuberculosis |
CN105816768A (en) * | 2016-05-11 | 2016-08-03 | 刘晓 | Medicine for treating pulmonary tuberculosis |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152502A (en) * | 2007-09-29 | 2008-04-02 | 翟绍荣 | Traditional Chinese medicine composition for treating tuberculosis and processes for producing same |
-
2013
- 2013-10-31 CN CN201310532331.5A patent/CN103550643A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101152502A (en) * | 2007-09-29 | 2008-04-02 | 翟绍荣 | Traditional Chinese medicine composition for treating tuberculosis and processes for producing same |
Non-Patent Citations (1)
Title |
---|
王妍: "《小儿百部止咳颗粒的成型工艺》", 《中国实验方剂学杂志》, vol. 17, no. 1, 31 January 2011 (2011-01-31), pages 21 - 22 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104815259A (en) * | 2015-05-23 | 2015-08-05 | 青岛辰达生物科技有限公司 | Traditional Chinese medicine composition for treating phthisis |
CN105031445A (en) * | 2015-06-29 | 2015-11-11 | 梁忠顺 | Chinese medicinal composition for treating pulmonary tuberculosis |
CN105726906A (en) * | 2016-05-11 | 2016-07-06 | 刘晓 | Traditional Chinese medicine for treating pulmonary tuberculosis |
CN105816768A (en) * | 2016-05-11 | 2016-08-03 | 刘晓 | Medicine for treating pulmonary tuberculosis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101766804B (en) | Chinese herbal composite for epistaxis treatment and preparation method thereof | |
CN103536889B (en) | One is treated senile chronic tracheitis and is merged emophysematous Chinese medicine decoction | |
CN104547496B (en) | A kind of Chinese medicine composition to moisten the lung and relieve the cough and preparation method thereof | |
CN102614286A (en) | Medicine for treating cold and preparation method for medicine | |
CN103550643A (en) | Traditional Chinese medicine for treating tuberculosis | |
CN103330826B (en) | Traditional Chinese medicine composition for treating deficiency of lung yin | |
CN104147447A (en) | Traditional Chinese medicine for treating pulmonary emphysema | |
CN103211990A (en) | Chinese medicinal composition for treating oral ulcer | |
CN103845407A (en) | Traditional Chinese medicine for treating chylothorax | |
CN102600336B (en) | Medicament for treating asthma | |
CN103611129A (en) | Traditional Chinese medicine for treating neuropathic headache | |
CN103405602A (en) | Medicament for treating asthma | |
CN104606523A (en) | Traditional Chinese medicine composition treating children's measles | |
CN104383097A (en) | Traditional Chinese medicine for treating lupus erythematosus | |
CN104258295A (en) | Traditional Chinese medicine decoction for treating lymphoma | |
CN103463444B (en) | Traditional Chinese medicine composition for treating phlegm stagnation cross-resistance type acnes | |
CN103536790A (en) | Traditional Chinese medicine for treating acute icteric hepatitis | |
CN102284023A (en) | Chinese medicinal composition for treating asthma | |
CN102836405B (en) | Medicament for treating encephaloma | |
CN104721283A (en) | Medicament for treating pulpitis | |
CN104606553B (en) | A kind of pharmaceutical composition for the treatment of hemopenia fever in puerperal | |
CN104887874A (en) | Traditional Chinese medicine composition for treating pneumonia | |
CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma | |
CN103263516B (en) | Medicine for treating cholecystitis | |
CN104758403A (en) | Traditional Chinese preparation for treating gastritis, enteritis, peptic ulcer and dyspepsia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140205 |